TNF-alpha Down-Regulates Filaggrin and Loricrin Through c-Jun N-Terminal Kinase: Role for TNF Antagonists to Improve Skin Barrier
Psoriasis is characterized by over-expression of TNF-alpha and impaired skin barrier. [...]we investigated whether skin barrier proteins are modulated by TNF-alpha, and determined the effect of clinical treatment with a TNF-alpha antagonist on barrier protein expression.
Saved in:
Published in: | Journal of allergy and clinical immunology Vol. 127; no. 2; p. AB148 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
St. Louis
Mosby, Inc
01-02-2011
Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Psoriasis is characterized by over-expression of TNF-alpha and impaired skin barrier. [...]we investigated whether skin barrier proteins are modulated by TNF-alpha, and determined the effect of clinical treatment with a TNF-alpha antagonist on barrier protein expression. |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2010.12.588 |